Lumenis Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology

Laser lithotripsy

Proven to be effective and efficient, MOSES 2.0 Technology optimizes stone ablation.1,2

Improving the gold standard for laser lithotripsy 

Its groundbreaking, patent-protected pulse delivery technology is designed to improve energy transmission, resulting in more efficient lithotripsy treatments compared to the standard holmium pulse.2

 

Moses 2.0 example of technology.
Checkmark in a circle icon.

Deliver optimized lithotripsy treatment 

MOSES pulse modulation technology delivers optimized laser energy. 

  • Up to 92% greater stone ablation with stone dusting at 120Hz in small-core MOSES fibers*,** 
  • 50% reduction in retropulsion compared with standard Holmium2 
  • Improved ablation at distance for various stone locations and compositions compared with standard holmium2
Checkmark in a circle icon.

Make stone removal more efficient*

  • Nearly 20% reduction in lithotripsy procedure time*2 
  • 33% improvement in treatment efficiency during mPCNL*3 
  • 33% improvement in stone fragmentation efficiency*2 

Interested in learning more about stone and BPH treatment?

Fill out this form, and a Boston Scientific representative will contact you soon. 

 

*Compared with standard holmium pulse.
**Bench test results may not necessarily be indicative of clinical performance. 

References:

  1. Elhilali MM, Badaan S, Ibrahim A, Andonian S. Use of the Moses technology to improve holmium laser lithotripsy outcomes: A preclinical study. J Endourol. 2017;31:598–604.  
  2. Ibrahim A, Elhilali MM, Fahmy N, Carrier S, Andonian S. Double-blinded prospective randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol. 2020;34:624–628. 
  3. Dunne M, Drescher M, Abbott J, Davalos J. Lumenis Pulse MOSES Technology improves efficiency of laser lithotripsy for patients undergoing mini-PCNL. J Urol. 2021;206:e318. 

Rx Only

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France. 

Boston Scientific acquired the global surgical business of Lumenis Ltd. Some registered names of products manufactured and sold by Boston Scientific may contain the term “Lumenis.” Lumenis is a registered trademark of Lumenis Be.

All images are the property of Boston Scientific.  All trademarks are the property of their respective owners.